Göran Tornling
Director/Miembro de la Junta en ACUCORT AB .
Perfil
Göran Tornling is currently an Independent Director at AcuCort AB, an Associate Professor at Karolinska Institutet, the Chief Medical Officer & Vice President at Biolipox AB, the Chief Medical Officer at AnaMar AB, and the Chief Medical Officer at Gesynta Pharma AB.
He previously worked as a Director-Medical Science at AstraZeneca R&D Boston, Inc. Dr. Tornling holds a doctorate degree from Karolinska Institutet.
Cargos activos de Göran Tornling
| Empresas | Cargo | Inicio |
|---|---|---|
| ACUCORT AB | Director/Miembro de la Junta | 01/01/2021 |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Director Técnico/Científico/I+D | 01/09/2006 |
| Karolinska Institutet | Corporate Officer/Principal | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Director Técnico/Científico/I+D | - |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Göran Tornling.
| Empresas | Cargo | Fin |
|---|---|---|
AstraZeneca R&D Boston, Inc.
 AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Göran Tornling.
| Karolinska Institutet | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACUCORT AB | Health Technology |
| Empresas privadas | 4 |
|---|---|
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Health Technology |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Health Technology |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Göran Tornling
